Jia-jie Shi
State Key Laboratory Of Quality Research In Chinese Medicine
Macao, 999078, China
Macao, 999078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dual blockade of GSTK1 and CD47 improves macrophage-mediated phagocytosis on cancer cells.
Journal: Biochemical pharmacology
Published: December 09, 2024
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer.
Journal: Frontiers of medicine
Published: December 30, 2021
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.
Journal: Journal of cancer research and clinical oncology
Published: March 17, 2021
Anticancer Effects of Ginsenoside Rh2: A Systematic Review.
Journal: Current molecular pharmacology
Published: September 28, 2020
The development of small-molecule inhibitors targeting CD47.
Journal: Drug discovery today
Published: April 10, 2020
Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus.
Journal: Biochemical pharmacology
Published: December 31, 2019
Investigational Hypoxia-Activated Prodrugs: Making Sense of Future Development.
Journal: Current drug targets
Published: August 28, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026